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To determine whether coronary artery bypass surgery 
would prolong survival in patients with silent myocardial 
ischemia during exercise testing, the data on 692 such 
patients from the Coronary Artery Surgery Study (CASS) 
registry were analyzed. The patients were followed up for 
up to 7 years after medical (n = 424) or surgical (n = 268) 
therapy. Stratification of patients into subsets was based on 
the results of cardiac catheterization. 
Surgical benefit was greatest in the patients with three 
vessel coronary artery disease or abnormal left ventricular 
Transient myocardial ischemia during exercise testing has 
been well documented to occur without associated angina in 
patients with coronary artery disease (1,2). The presence of 
exercise-induced ischemia has an adverse effect on survival 
whether or not it is accompanied by angina (3,4). This impact 
appears to be greater among patients with severe coronary 
artery disease (4). 
The therapeutic approach to these patients is controver-
sial. The initial treatment usually is medications in an 
attempt to abolish both symptomatic and silent episodes of 
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function. Among the 75 patients with three vessel coronary 
disease and left ventricular dysfunction, the 7 year survival 
rate was 37% for the medical group and 90% for the 
surgical group (p < 0.0001). Thus, among patients with 
silent myocardial ischemia during exercise testing in this 
nonrandomized study, survival appeared to be enhanced by 
coronary artery bypass surgery in subsets of patients with 
severe coronary artery disease and abnormal left ventricu-
lar function. 
(J Am Coli CardioI1988;12:595-9) 
ischemia (5-7). The effect of coronary artery bypass graft 
surgery on patients who continue to display exercise-
induced silent ischemia has not been previously studied. 
The present investigation compared the impact of surgical 
and medical therapy on patients with silent myocardial 
ischemia during exercise testing. Patients were stratified on 
the basis of the severity of coronary artery disease and of left 
ventricular function in order to identify subsets of patients in 
whom surgical treatment had its greatest benefit. 
Methods 
Study patients. The study population consisted of 692 
patients from the Coronary Artery Surgery Study (CASS) 
registry who underwent cardiac catheterization and an exer-
cise test within 1 month of the catheterization. The patients 
were followed up at yearly intervals for at least 5 years. 
Overall, the follow-up was 99% complete. 
Exercise test. The patients were exercised to a symptom-
limited maximal end point on a graded exercise test using the 
Bruce and Hornsten (8) protocol. The most frequent end 
points of the exercise test included weakness or fatigue 
(45%), dyspnea (28%), physician request (20%) and lower 
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limb claudication (5%). During exercise testing, all patients 
manifested silent myocardial ischemia, which was defined as 
the presence of at least 1 mm horizontal or downsloping ST 
segment depression measured at 0.08 s after the J point 
without the development of anginal chest pain either during 
exercise or during recovery. 
Cardiac catheterization. All patients had clinically impor-
tant coronary artery disease, which was defined as 2::70% 
narrowing of the luminal diameter in the left anterior de-
scending, left circumflex or right coronary artery or their 
major branches or 2::50% luminal diameter narrowing of the 
left main coronary artery. 
A left ventricular contraction score (range 5 to 30) was 
calculated on the basis of a subjective grading of the left 
ventricular angiogram as described previously (9). For the 
purpose of this analysis, left ventricular function was con-
sidered preserved if the score was 5 to 9 and abnormal if the 
score was 2:: 10. 
Statistical methods. Group differences at baseline were 
assessed by the chi-square test for discrete variables. Con-
tinuous variables were compared by the two-sample t test. 
Cumulative survival curves were calculated with the life 
table method and were presented for 7 years. Differences 
between the survival curves for the medical and surgical 
groups were assessed by the use of a log-rank statistic with 
the corresponding p values computed from all the follow-up 
data (10). The significance of additional variables in the 
survival analysis was assessed by a Cox proportional haz-
ards model (11). 
Because patients were not randomized to medical or 
surgical therapy in this study, the actual therapy received 
was at the discretion of the patients and their physicians. 
The survival rates of the surgically and medically treated 
patients were compared by a statistical approach previously 
described in CASS registry studies (12,13). 
Results 
Baseline characteristics (Table 1). The distribution of 
baseline characteristics of the 424 medically treated and 268 
surgically treated patients with silent ischemia during exer-
cise testing is shown in Table 1. Thirty-two percent of the 
patients did not experience angina during their normal 
activities at the baseline evaluation. The medically treated 
patients were more likely to have poorer left ventricular 
function and more severe congestive heart failure although 
the latter variable was present iri only 6% of patients. The 
surgically treated patients had more severe angina, more 
extensive coronary artery disease and a higher percent of 
associated illnesses. 
Predictors of survival (Table 2). The variables that were 
selected by the stepwise Cox proportional hazards model as 
having the most important impact on survival were the 
number of coronary vessels diseased, the left ventricular 
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Table 1. Baseline Characteristics of the Medical and 
Surgical Groups 
Medical Surgical 
(n = 424) (n = 268) 
Variables (%) (%) p Value 
Clinical 
Age >60 years 334 (79) 207 (77) 0.631 
Male gender 369 (87) 238 (89) 0.492 
Congestive heart failure 27 (6) 2 (1) 0.005 
score >3 
Classification of angina 
None 149 (35) 70 (26) 
45 (10) 19 (7) 
2 140 (33) 96 (36) 
3 48 (11) 52 (19) 
4 8 (2) 12 (5) 0.003 
Prior myocardial infarction 242 (57) 136 (51) 0.162 
One or more associated 294 (69) 206 (77) 0.011 
illnesses 
Beta-blocker therapy 156 (37) 111 (41) 0.221 
Long-acting nitrate therapy 164 (39) 109 (41) 0.571 
Arteriographic 
One vessel disease 150 (35) 45 (17) 
Two vessel disease 145 (34) 93 (35) 
Three vessel disease 124 (29) 129 (48) 0.001 
Hemodynamic 
Left ventricular score > I 0 103 (24) 42 (16) 0.032 
Left ventricular end 70 (17) 38 (14) 0.419 
diastolic pressure 2: 19 
mmHg 
Exercise test 
Final exercise stage 
o to 1 102 (24) 80 (30) 
2 115 (27) 78 (29) 
d 205 (48) 110 (42) 0.615 
score and the number of associated medical illnesses. In 
addition, an independent beneficial effect of surgical therapy 
was found. The patients were then stratified in different 
subgroups on the basis of the number of diseased coronary 
vessel~ and the left ventricular score. Cumulative survival 
curves between the medical and surgical groups were com-
pared in these subsets. 
Survival rates among the stratified groups. There was no 
significant difference in survival rates between the medical 
and surgical groups among patients with one vessel and two 
vessel coronary artery disease (Fig. 1) By contrast, among 
patients with three vessel coronary disease, surgical therapy 
resulted in a marked improvement in survival. The survival 
curves of the medical and surgical groups were quite similar 
among patients with preserved left ventricular function (Fig. 
2). There was, however, a significant beneficial effect of 
surgery among patients with abnormal left ventricular func-
tion. 
Among patients with three vessel coronary artery disease 
and preserved left ventricular function, there was no signif-
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Table 2. Predictors of Survival by Multivariate Analysis 
Beta 
Covariate Coefficient 
No. of vessels diseased 0.68 
Left ventricular score 0.08 
Illness count 0.23 
Therapy (medical = 0 or surgical = \) -0.51 
icant difference in the survival curves, although a trend 
toward improved survival among the surgically treated pa-
tients was observed (Fig. 3). The greatest difference between 
the survival curves of the medically and surgically treated 
patients with silent myocardial ischemia was found among 
patients with three vessel coronary disease and abnormal left 
ventricular function (37 versus 90%, respectively; p < 
0.0001). 
Discussion 
Prior studies on silent ischemia. The presence of transient 
myocardial ischemia without associated angina has been 
detected both by exercise testing and by ambulatory or 
telemetry electrocardiographic (ECG) monitoring. Episodes 
of silent myocardial ischemia may occur in 80% of patients 
with angina and in 40% of patients after a myocardial 
infarction (4-6). Most patients with active coronary artery 
disease have episodes of both symptomatic and silent ische-
mia, although silent episodes are recorded more frequently 
when the patients are evaluated by ambulatory ECG moni-
toring than by other types of testing. In the present study, 
although all the patients had silent ischemia by exercise 
testing, 65% of the medical group and 74% of the surgical 
group had episodes of angina during their normal activities. 
Previous investigations (3,4,14) have documented that the 
presence of transient myocardial ischemia during exercise 
testing has an adverse impact on survival. Both the mortality 
Figure 1. Cumulative survival rates for the medically (dashed lines) 
and surgically (solid lines) treated patients according to the number 
of diseased coronary vessels. The survival curves were similar for 
patients with one and two vessel coronary disease but differed 
significantly favoring surgical therapy in patients with three vessel 
disease. 
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and the risk of subsequent acute myocardial infarction are 
higher in patients with ischemia during exercise testing than 
in patients who do not have this abhormality (4,15). The 
additional presence of angina during exercise testing does 
not have an independent effect on survival as judged from 
previous studies from the CASS registry (4) and other 
investigations (3,16). There are many drugs that will de-
crease the number of silent and symptomatic episodes of 
ischemia (7). No previous study, however, has analyzed the 
impact of coronary artery bypass surgery on patients who 
manifest silent myocardial ischemia during exercise testing. 
Impact of coronary bypass surgery: present study. Be-
cause the extent of coronary artery disease and the presence 
of left ventricular dysfunction had such a marked impact on 
survival, the patients were stratified according to these two 
variables in order to identify subsets of patients in whom 
surgical therapy would be especially beneficial. Our results 
indicated that coronary bypass surgery does not improve 
survival among patients with only one or two vessel coro-
nary artery disease or among those with preserved left 
ventricular function. 
The patients with silent ischemia during exercise testing 
who were at the highest risk were those with three vessel 
coronary disease and abnormal left ventricular function. In 
this group, the 7 year survival rate among the medically 
treated patients was only 37%, and surgical therapy had the 
greatest benefit (7 year survival rate 90%). Even among 
patients with silent ischemia, three vessel coronary artery 
Figure 2. Cumulative survival rates for all the medically (dashed 
lines) and surgically (solid lines) treated patients in relation to 
function of the left ventricle (LV). Improved survival in the surgi-
cally treated patients was found among patients with abnormal 
(score 2:10) left ventricular function but not with preserved (score 
::::9) function. 
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Figure 3. Cumulative survival rates for the medically (dashed lines) 
and surgically (solid lines) treated patients with three vessel coro-
nary artery disease in relation to function of the left ventricle (LV). 
The survival curve for the surgically treated patients was signifi-
cantly better than that of the medically treated patients when 
abnormal left ventricular function was present. Among patients with 
preserved left ventricular function, only a trend favoring surgical 
therapy was found. 
disease and preserved left ventricular function, surgical 
therapy appeared to be better than medical treatment al-. 
though the differences in survival did not achieve statistical 
significance. 
Limitations of the study. The decision to perform coro-
nary artery bypass surgery among patients with exercise-
induced silent myocardial ischemia was not randomized in 
this study. This introduces the bias of a nonrandomized 
study design resulting in differences in the baseline charac-
teristics of the two groups of patients (17). We tried to 
minimize this bias by using a Cox proportional hazards 
model to account for the baseline differences between the 
two groups and by stratifying the patients into subgroups 
based on the important predictors of survival. 
Conclusions. The results of our study in patients with 
silent myocardial ischemia do not differ substantially from 
those of other studies (18-20) on the impact of coronary 
bypass surgery among patients with coronary artery disease. 
The risk for these patients with silent ischemia appears to be 
greatest in those with severe coronary artery disease and 
abnormal left ventricular function. It is in this subset of 
patients that coronary artery bypass surgery has its greatest 
impact on improved survival. 
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University of Alabama in Birmingham. William J. Rogers, MD,' Richard 
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Boston University. Thomas J. Ryan, MD,' Robert L. Berger, MD,"David 
P. Faxon, MD, Carolyn H. McCabe, BS, Donald A. Weiner, MD, Laura F. 
Wexler, MD 
Lorna Linda University. Melvin P. Judkins, MD,' Patrick M. Moloney, 
MD 
Marshfield Medical Foundation, Inc,. William O. Myers, MD,* Richard D. 
Sautter, MD,* John N. Bowell, MD, Dieter M. Voss, MD, Robert D. Carlson, 
MD 
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Massachusetts General Hospital. J. Warren Harthorne, MD,* W. Gerald 
Austen, MD, Robert Dinsmore, MD, Frederick Levine, MD, John McDer-
mott, MD, Frederick Poulin, MD 
Mayo Clinic and Mayo Foundation. Robert L. Frye, MD,' Hugh C. Smith, 
MD, Bernard J. Gersh, MD, Ronald E. Vlietstra, MD, Richard E. Fulton, 
MD, Michael B. Mock, MD 
Miami Heart Institute. Arthur J. Gosselin, MD,* Parry B. Larsen, MD, 
Paul S. Swaye, MD 
Montreal Heart Institute. Martial G. Bourassa, MD,' lacques Lesperance, 
MD, Claude Goulet, MD, Claude M. Grondin, MD 
New York University. Ephraim Glassman, MD,' Michael Schloss, MD, O. 
Wayne Isom, MD 
St. Louis University. George C. Kaiser, MD,* 1. Gerard Mudd, MD,* 
Henrick B. Barner, MD, John E. Codd, MD, Hillel M. Laks, MD, Bernard R. 
Chaitman, MD, Denis H. Tyras, MD, Robert D. Weins, MD, Vallee L. 
Willman, MD 
St. Luke's Hospital Center, New York. Harvey G. Kemp, Jr, MD,' Airlie 
Cameron, MD 
Stanford University. Edwin L. Alderman, MD,* lames F. Silverman, 
MD,* Edward B. Stinson, MD 
Medical College of Wisconsin. Felix Tristani, MD,* Robert 1. Flemma, 
MD, Harold R. Brooks, MD 
Yale University. Lawrence S. Cohen, MD,* Alexander S. Geha, MD, 
Graeme L. Hammond, MD, Rene Langou, MD, Richard K. Shaw, MD 
Coordinating Center 
University of Washington, Kathryn B. Davis, PhD,* Lloyd D. Fisher, 
PhD,* Mary 10 Gillespie, MD, 1. Ward Kennedy, MD, Richard A. Kronmal, 
PhD 
Central Electrocardiographic Laboratory 
University of Alabama at Birmingham, L. Thomas Sheffield, MD' 
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Chairman: Thomas Killip, MD; Committee Members: Eugene R. Passa-
mani, MD, Charles G. Hollingsworth, Dr PH, Peter L. Frommer, MD 
'Denotes principal investigator. 
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